Skip to main content
Log in

Troponinerhöhung beim akuten ischämischen Schlaganfall – unspezifisch oder Ausdruck eines akuten Myokardinfarkts?

Diagnostik und klinische Implikationen

Troponin elevation in acute ischemic stroke—unspecific or acute myocardial infarction?

Diagnostics and clinical implications

  • Übersichten
  • Published:
Herz Aims and scope Submit manuscript

Zusammenfassung

Für alle Patienten mit akutem ischämischen Schlaganfall wird die routinemäßige Troponinbestimmung empfohlen. Bei 20–55 % dieser Patienten ist der Troponinwert erhöht, wobei hierfür neben der ischämischen auch die nichtischämische Myokardschädigung sowie im Besonderen der neurokardiogene Myokardschaden ursächlich sein können. Bei Patienten mit akutem ischämischen Schlaganfall wird die Prävalenz einer bisher nicht bekannten koronaren Herzkrankheit mit bis zu 27 % angegeben und ist für dieses Kollektiv prognosebestimmend. Allerdings können bei Schlaganfallpatienten mit Troponinerhöhung im Vergleich zu Patienten mit einem Nicht-ST-Strecken-Hebungs-Myokardinfarkt seltener relevante Koronarstenosen nachgewiesen werden. Das Risiko einer sekundären intrazerebralen Hämorrhagie durch die Notwendigkeit einer dualen Thrombozytenaggregationshemmung verdeutlicht die herausfordernde Indikationsstellung zur invasiven Koronardiagnostik und -revaskularisation. Daher sind eine der Dringlichkeit angemessene diagnostische Aufarbeitung und interdisziplinäre Risikoevaluation notwendig, um ein sinnvolles therapeutisches Vorgehen mit Zeitpunkt der Intervention sowie Art und Dauer der Blutverdünnung festlegen zu können. Neben konventionellen Untersuchungsmethoden steht hierfür immer häufiger auch eine erweiterte kardiale Bildgebung zur Verfügung. Diese Übersichtsarbeit möchte einen pragmatischen und klinisch orientierten Ansatz zum diagnostischen und therapeutischen Vorgehen unter Berücksichtigung der vorhandenen Evidenz aufzeigen.

Abstract

Routine determination of troponin levels is recommended for all patients with acute ischemic stroke. In 20–55% of these patients the troponin levels are elevated, which may be caused by ischemic as well as non-ischemic myocardial damage and particularly neurocardiogenic myocardial damage. In patients with acute ischemic stroke, the prevalence of previously unknown coronary heart disease is reported to be up to 27% and is prognostically relevant for these patients; however, relevant coronary stenoses are less frequently detected in stroke patients with troponin elevation compared to patients with non-ST elevation myocardial infarction. The risk of secondary intracerebral hemorrhage due to the necessity for dual platelet aggregation inhibition illustrates the challenging indication for invasive coronary diagnostics and revascularization. Therefore, a diagnostic work-up and interdisciplinary risk evaluation appropriate to the urgency are necessary in order to be able to determine a reasonable treatment approach with timing of the intervention, type and duration of blood thinning. In addition to conventional examination methods, multimodal cardiac imaging is increasingly used for this purpose. This review article aims to provide a pragmatic and clinically oriented approach to diagnostic and therapeutic procedures, taking into account the available evidence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2
Abb. 3
Abb. 4

Literatur

  1. Prosser J, MacGregor L, Lees KR, Diener HC, Hacke W, Davis S (2007) Predictors of early cardiac morbidity and mortality after ischemic stroke. Stroke 38(8):2295–2302

    Article  PubMed  Google Scholar 

  2. Amarenco P, Lavallee PC, Labreuche J, Ducrocq G, Juliard JM, Feldman L et al (2011) Prevalence of coronary atherosclerosis in patients with cerebral infarction. Stroke 42(1):22–29

    Article  PubMed  Google Scholar 

  3. Gongora-Rivera F, Labreuche J, Jaramillo A, Steg PG, Hauw JJ, Amarenco P (2007) Autopsy prevalence of coronary atherosclerosis in patients with fatal stroke. Stroke 38(4):1203–1210

    Article  PubMed  Google Scholar 

  4. Adelborg K, Szepligeti S, Sundboll J, Horvath-Puho E, Henderson VW, Ording A et al (2017) Risk of stroke in patients with heart failure: a population-based 30-year cohort study. Stroke 48(5):1161–1168

    Article  PubMed  Google Scholar 

  5. Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K et al (2018) 2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 49(3):e46–e110

    Article  PubMed  Google Scholar 

  6. Scheitz JF, Mochmann HC, Erdur H, Tutuncu S, Haeusler KG, Grittner U et al (2014) Prognostic relevance of cardiac troponin T levels and their dynamic changes measured with a high-sensitivity assay in acute ischaemic stroke: analyses from the TRELAS cohort. Int J Cardiol 177(3):886–893

    Article  PubMed  Google Scholar 

  7. Mochmann HC, Scheitz JF, Petzold GC, Haeusler KG, Audebert HJ, Laufs U et al (2016) Coronary angiographic findings in acute ischemic stroke patients with elevated cardiac troponin: the troponin elevation in acute ischemic stroke (TRELAS) study. Circulation 133(13):1264–1271

    Article  CAS  PubMed  Google Scholar 

  8. Giannitsis E, Katus HA (2013) Cardiac troponin level elevations not related to acute coronary syndromes. Nat Rev Cardiol 10(11):623–634

    Article  CAS  PubMed  Google Scholar 

  9. Scheitz JF, Nolte CH, Doehner W, Hachinski V, Endres M (2018) Stroke-heart syndrome: clinical presentation and underlying mechanisms. Lancet Neurol 17(12):1109–1120

    Article  PubMed  Google Scholar 

  10. Katus HA, Remppis A, Looser S, Hallermeier K, Scheffold T, Kubler W (1989) Enzyme linked immuno assay of cardiac troponin T for the detection of acute myocardial infarction in patients. J Mol Cell Cardiol 21(12):1349–1353

    Article  CAS  PubMed  Google Scholar 

  11. Newby LK, Jesse RL, Babb JD, Christenson RH, De Fer TM, Diamond GA et al (2012) ACCF 2012 expert consensus document on practical clinical considerations in the interpretation of troponin elevations: a report of the American College of Cardiology Foundation task force on Clinical Expert Consensus Documents. J Am Coll Cardiol 60(23):2427–2463

    Article  PubMed  Google Scholar 

  12. Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA et al (2018) Fourth universal definition of myocardial infarction (2018). J Am Coll Cardiol 72(18):2231–2264

    Article  PubMed  Google Scholar 

  13. Kumar S, Selim MH, Caplan LR (2010) Medical complications after stroke. Lancet Neurol 9(1):105–118

    Article  PubMed  Google Scholar 

  14. Dütsch M, Burger M, Dorfler C, Schwab S, Hilz MJ (2007) Cardiovascular autonomic function in poststroke patients. Neurology 69(24):2249–2255

    Article  PubMed  Google Scholar 

  15. Wybraniec M, Mizia-Stec K, Krzych L (2014) Stress cardiomyopathy: yet another type of neurocardiogenic injury: ‘stress cardiomyopathy’. Cardiovasc Pathol 23(3):113–120

    Article  PubMed  Google Scholar 

  16. Yoshimura S, Toyoda K, Ohara T, Nagasawa H, Ohtani N, Kuwashiro T et al (2008) Takotsubo cardiomyopathy in acute ischemic stroke. Ann Neurol 64(5):547–554

    Article  PubMed  Google Scholar 

  17. Cheshire WP Jr, Saper CB (2006) The insular cortex and cardiac response to stroke. Neurology 66(9):1296–1297

    Article  PubMed  Google Scholar 

  18. Krause T, Werner K, Fiebach JB, Villringer K, Piper SK, Haeusler KG et al (2017) Stroke in right dorsal anterior insular cortex Is related to myocardial injury. Ann Neurol 81(4):502–511

    Article  CAS  PubMed  Google Scholar 

  19. Ay H, Koroshetz WJ, Benner T, Vangel MG, Melinosky C, Arsava EM et al (2006) Neuroanatomic correlates of stroke-related myocardial injury. Neurology 66(9):1325–1329

    Article  CAS  PubMed  Google Scholar 

  20. Scheitz JF, Mochmann HC, Nolte CH, Haeusler KG, Audebert HJ, Heuschmann PU et al (2011) Troponin elevation in acute ischemic stroke (TRELAS)—protocol of a prospective observational trial. BMC Neurol 11:98

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Gerner ST, Auerbeck K, Sprugel MI, Sembill JA, Madzar D, Golitz P et al (2018) Peak troponin I levels are associated with functional outcome in intracerebral hemorrhage. Cerebrovasc Dis 46(1–2):72–81

    Article  CAS  PubMed  Google Scholar 

  22. Masuda T, Sato K, Yamamoto S, Matsuyama N, Shimohama T, Matsunaga A et al (2002) Sympathetic nervous activity and myocardial damage immediately after subarachnoid hemorrhage in a unique animal model. Stroke 33(6):1671–1676

    Article  PubMed  Google Scholar 

  23. Kerr G, Ray G, Wu O, Stott DJ, Langhorne P (2009) Elevated troponin after stroke: a systematic review. Cerebrovasc Dis 28(3):220–226

    Article  CAS  PubMed  Google Scholar 

  24. de Lemos JA, Drazner MH, Omland T, Ayers CR, Khera A, Rohatgi A et al (2010) Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA 304(22):2503–2512

    Article  PubMed  PubMed Central  Google Scholar 

  25. Feher G, Tibold A, Koltai K, Szapary L (2014) The clinical importance of troponin elevation in ischaemic cerebrovascular events: a clinical review. J Cardiol Ther 1(7):141–149

    Google Scholar 

  26. Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F et al (2016) 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European society of cardiology (ESC). Eur Heart J 37(3):267–315

    Article  CAS  PubMed  Google Scholar 

  27. Anders B, Alonso A, Artemis D, Schafer A, Ebert A, Kablau M et al (2013) What does elevated high-sensitive troponin I in stroke patients mean: concomitant acute myocardial infarction or a marker for high-risk patients. Cerebrovasc Dis 36(3):211–217

    Article  CAS  PubMed  Google Scholar 

  28. Hankey GJ (2017) Stroke. Lancet 389(10069):641–654

    Article  PubMed  Google Scholar 

  29. Zhang ZM, Rautaharju PM, Prineas RJ, Rodriguez CJ, Loehr L, Rosamond WD, Kitzman D, Couper D, Soliman EZ (2016) Race and sex differences in the incidence and prognostic significance of silent myocardial infarction in the atherosclerosis risk in communities (ARIC) study. Circulation 133(22):2141–2148. https://doi.org/10.1161/CIRCULATIONAHA.115.021177

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B et al (2016) 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 37(38):2893–2962

    Article  PubMed  Google Scholar 

  31. Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K et al (2019) Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 50(12):e344–e418

    Article  PubMed  Google Scholar 

  32. Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H et al (2018) 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 39(2):119–177

    Article  PubMed  Google Scholar 

  33. Laufs U, Hoppe UC, Rosenkranz S, Kirchhof P, Bohm M, Diener HC et al (2010) Cardiac workup after cerebral ischemia. Consensus paper of the Working Group on Heart and Brain of the German Cardiac Society and German Stroke Society. Nervenarzt 81(4):444–462

    Article  CAS  PubMed  Google Scholar 

  34. Kontos MC, Diercks DB, Kirk JD (2010) Emergency department and office-based evaluation of patients with chest pain. Mayo Clin Proc 85(3):284–299

    Article  PubMed  PubMed Central  Google Scholar 

  35. Cheitlin MD, Armstrong WF, Aurigemma GP, Beller GA, Bierman FZ, Davis JL et al (2003) ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article. J Am Soc Echocardiogr 16(10):1091–1110

    PubMed  Google Scholar 

  36. de Bruijn SFTM, Agema WRP, Lammers GJ, van der Wall EE, Wolterbeek R, Holman ER et al (2006) Transesophageal echocardiography is superior to transthoracic echocardiography in management of patients of any age with transient ischemic attack or stroke. Stroke 37(10):2531–2534

    Article  PubMed  Google Scholar 

  37. Task Force Members, Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C et al (2013) 2013 ESC guidelines on the management of stable coronary artery disease: the task force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 34(38):2949–3003

    Article  Google Scholar 

  38. Fairbairn TA, Nieman K, Akasaka T, Norgaard BL, Berman DS, Raff G et al (2018) Real-world clinical utility and impact on clinical decision-making of coronary computed tomography angiography-derived fractional flow reserve: lessons from the ADVANCE registry. Eur Heart J 39(41):3701–3711. https://doi.org/10.1093/eurheartj/ehy530

    Article  PubMed  PubMed Central  Google Scholar 

  39. Renker M, Schoepf UJ, Becher T, Krampulz N, Kim W, Rolf A et al (2017) Computed tomography in patients with chronic stable angina: fractional flow reserve measurement. Herz 42(1):51–57

    Article  CAS  PubMed  Google Scholar 

  40. Achenbach S, Barkhausen J, Beer M, Beerbaum P, Dill T, Eichhorn J et al (2012) Konsensusempfehlungen der DRG/DGK/DGPK zum Einsatz der Herzbildgebung mit Computertomographie und Magnetresonanztomographie. Kardiologe 6(2):105–125

    Article  Google Scholar 

  41. Lin CK, McDonough RJ, Prentice RL, Thomas DM, Steel KE, Rubal BJ et al (2014) Assessment of major adverse cardiovascular events and ischemic stroke with coronary computed tomography angiography based upon angiographic diagnosis in a high-volume single center. Sage Open Med 2:2050312114533535

    Article  PubMed  PubMed Central  Google Scholar 

  42. Hur J, Lee KH, Hong SR, Suh YJ, Hong YJ, Lee HJ et al (2015) Prognostic value of coronary computed tomography angiography in stroke patients. Atherosclerosis 238(2):271–277

    Article  CAS  PubMed  Google Scholar 

  43. Mushtaq S, Conte E, Melotti E, Andreini D (2019) Coronary CT angiography in challenging patients: high heart rate and atrial fibrillation. A review. Acad Radiol 26(11):1544–1549

    Article  PubMed  Google Scholar 

  44. Camen S, Haeusler KG, Schnabel RB (2019) Cardiac imaging after ischemic stroke: echocardiography, CT, or MRI? Herz 44(4):296–303

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Haeusler KG, Wollboldt C, Bentheim LZ, Herm J, Jäger S, Kunze C et al (2017) Feasibility and diagnostic value of cardiovascular magnetic resonance imaging after acute ischemic stroke of undetermined origin. Stroke 48(5):1241–1247

    Article  PubMed  Google Scholar 

  46. Weinsaft JW, Kim HW, Shah DJ, Klem I, Crowley AL, Brosnan R et al (2008) Detection of left ventricular thrombus by delayed-enhancement cardiovascular magnetic resonance prevalence and markers in patients with systolic dysfunction. J Am Coll Cardiol 52(2):148–157

    Article  PubMed  Google Scholar 

  47. Faber T, Rippy A, Hyslop WB, Hinderliter A, Sen S (2013) Cardiovascular MRI in detection and measurement of aortic atheroma in stroke/TIA patients. J Neurol Disord 1(4):139

    PubMed  PubMed Central  Google Scholar 

  48. Kim HW, Van Assche L, Jennings RB, Wince WB, Jensen CJ, Rehwald WG et al (2015) Relationship of T2-weighted MRI myocardial hyperintensity and the ischemic area-at-risk. Circ Res 117(3):254–265

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C et al (2020) 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J 41(3):407–477

    Article  PubMed  Google Scholar 

  50. Lyon AR, Bossone E, Schneider B, Sechtem U, Citro R, Underwood SR et al (2016) Current state of knowledge on Takotsubo syndrome: a position statement from the taskforce on Takotsubo syndrome of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 18(1):8–27

    Article  PubMed  Google Scholar 

  51. Kim HW, Farzaneh-Far A, Kim RJ (2009) Cardiovascular magnetic resonance in patients with myocardial infarction: current and emerging applications. J Am Coll Cardiol 55(1):1–16

    Article  PubMed  Google Scholar 

  52. Beek AM, van Rossum AC (2010) Cardiovascular magnetic resonance imaging in patients with acute myocardial infarction. Heart 96(3):237–243

    Article  PubMed  Google Scholar 

  53. Pijls NH, Fearon WF, Tonino PA, Siebert U, Ikeno F, Bornschein B et al (2010) Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2‑year follow-up of the FAME (fractional flow reserve versus angiography for multivessel evaluation) study. J Am Coll Cardiol 56(3):177–184

    Article  PubMed  Google Scholar 

  54. De Bruyne B, Pijls NH, Kalesan B, Barbato E, Tonino PA, Piroth Z et al (2012) Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med 367(11):991–1001

    Article  CAS  PubMed  Google Scholar 

  55. Ahn JM, Park DW, Shin ES, Koo BK, Nam CW, Doh JH et al (2017) Fractional flow reserve and cardiac events in coronary artery disease: data from a prospective IRIS-FFR registry (interventional cardiology research incooperation society fractional flow reserve). Circulation 135(23):2241–2251

    Article  PubMed  Google Scholar 

  56. Hochman JS, Reynolds HR, Bangalore S, O’Brien SM, Alexander KP, Senior R et al (2019) Baseline characteristics and risk profiles of participants in the ISCHEMIA randomized clinical trial. JAMA Cardiol 4(3):273–286

    Article  PubMed  PubMed Central  Google Scholar 

  57. Diener HC, Weber R (2013) Clopidogrel added to aspirin adds no benefit but bleeding risk in patients with recent lacunar stroke. Stroke 44(3):861–863

    Article  PubMed  Google Scholar 

  58. Amsterdam EA, Wenger NK, Brindis RG, Casey DE Jr, Ganiats TG, Holmes DR Jr et al (2014) 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation 130(25):e344–e426

    PubMed  Google Scholar 

  59. Pan Y, Elm JJ, Li H, Easton JD, Wang Y, Farrant M et al (2019) Outcomes associated with clopidogrel-aspirin use in minor stroke or transient ischemic attack: a pooled analysis of clopidogrel in high-risk patients with acute non-disabling cerebrovascular events (CHANCE) and platelet-oriented inhibition in new TIA and minor ischemic stroke (POINT) trials. JAMA Neurol 76(12):1466–1473. https://doi.org/10.1001/jamaneurol.2019.2531

    Article  PubMed  PubMed Central  Google Scholar 

  60. Poldervaart JM, Langedijk M, Backus BE, Dekker IMC, Six AJ, Doevendans PA et al (2017) Comparison of the GRACE, HEART and TIMI score to predict major adverse cardiac events in chest pain patients at the emergency department. Int J Cardiol 227:656–661

    Article  CAS  PubMed  Google Scholar 

  61. The ACTIVE Writing Group on behalf of the ACTIVE Investigators (2006) Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (ACTIVE W): a randomised controlled trial. Lancet 367(9526):1903–1912

    Article  CAS  Google Scholar 

  62. Aad G, Abajyan T, Abbott B, Abdallah J, Abdel Khalek S, Abdinov O et al (2013) Measurement of top quark polarization in top-antitop events from proton-proton collisions at √s = 7 TeV using the ATLAS detector. Phys Rev Lett 111(23):232002

    Article  PubMed  CAS  Google Scholar 

  63. Hochman JS, Lamas GA, Buller CE, Dzavik V, Reynolds HR, Abramsky SJ et al (2006) Coronary intervention for persistent occlusion after myocardial infarction. N Engl J Med 355(23):2395–2407

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Haeusler KG, Jensen C, Scheitz JF, Krause T, Wollboldt C, Witzenbichler B et al (2019) Cardiac magnetic resonance imaging in patients with acute ischemic stroke and elevated troponin: a TRoponin ELevation in Acute ischemic Stroke (TRELAS) sub-study. Cerebrovasc Dis Extra 9(1):19–24

    Article  PubMed  PubMed Central  Google Scholar 

  65. Laufs U, Hoppe UC, Rosenkranz S, Kirchhof P, Böhm M, Diener HC et al (2010) Kardiologische Diagnostik nach zerebraler Ischämie. Nervenarzt 81(4):444–462

    Article  CAS  PubMed  Google Scholar 

  66. Sposato LA, Lam M, Allen B, Shariff SZ, Saposnik G (2020) First-ever ischemic stroke and incident major adverse cardiovascular events in 93 627 older women and men. Stroke 51(2):387–394

    Article  PubMed  Google Scholar 

  67. Scheitz JF, Nolte CH, Laufs U, Endres M (2015) Application and interpretation of high-sensitivity cardiac troponin assays in patients with acute ischemic stroke. Stroke 46(4):1132–1140

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S. Baumann.

Ethics declarations

Interessenkonflikt

M. Kruska, C. Fastner, J.F. Scheitz, A. Kolb, M. Rutsch, T. Papavassiliu, M. Borggrefe, A. Alonso, I. Akin, K. Szabo und S. Baumann geben an, dass kein Interessenkonflikt besteht.

Dieser Beitrag enthält keine Studie an Menschen und Tieren.

Additional information

Die Autoren M. Kruska und C. Fastner teilen sich die Erstautorschaft.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kruska, M., Fastner, C., Scheitz, J.F. et al. Troponinerhöhung beim akuten ischämischen Schlaganfall – unspezifisch oder Ausdruck eines akuten Myokardinfarkts?. Herz 46, 342–351 (2021). https://doi.org/10.1007/s00059-020-04967-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00059-020-04967-3

Schlüsselwörter

Keywords

Navigation